BlueWhale Bio
Developer of a cell-based therapeutic platform intended to overcome bottlenecks in gene therapy manufacturing. The company's platform utilizes Synecta Activation, which facilitates cell-derived nanopa...
Valuation
$52M
Latest known
Share Price
N/A
Total Raised
$23M
Last Round
N/A